Testosterone treatment for women is a limited option, not a routine response to a low lab result. In the United States, no specific testosterone treatment has been approved by the FDA for women, and there’s no defined testosterone level that establishes a deficiency. Treatment for low testosterone in women may be considered in select cases, particularly for postmenopausal women experiencing persistent low sexual desire after other possible causes have been assessed.
It’s understandable to link low energy or reduced libido with a hormone change, especially after menopause. But these symptoms can have other causes, and a testosterone result alone can’t determine whether treatment is appropriate. Evidence is strongest for addressing low sexual desire; support for using testosterone to treat other symptoms remains insufficient.
This article explains how research on testosterone therapy after menopause informs treatment decisions, what side effects and breast cancer risks to discuss, and how dosing and monitoring are approached. It also explains why an individualized assessment matters when weighing possible benefits against uncertainties about long-term safety.
Key Takeaways
- Understand why a testosterone result alone doesn’t establish a need for treatment, and which symptom has the strongest evidence for therapy.
- Learn which side effects and health factors matter when weighing potential benefits against risks.
- See how cautious dosing and regular blood tests help guide treatment and follow-up.
- Explore what research says about breast cancer risk and testosterone therapy after menopause, including where important uncertainties remain.
- Find out what to consider before deciding whether treatment is an appropriate part of your care.
Should Women Get Treatment for Low Testosterone?
Deciding whether treatment for low testosterone in women is appropriate requires more than interpreting a single lab result. Symptoms, possible contributing conditions, and the evidence for a specific treatment goal all matter.
Symptoms Linked to Low Testosterone
Symptoms sometimes associated with lower testosterone include reduced sexual desire or satisfaction, fatigue, and low energy. These changes can affect daily life and relationships, but they don’t establish a hormone condition on their own. Low estrogen, sleep problems, stress, mood changes, and other health conditions can cause overlapping symptoms. Fatigue alongside reduced libido, for example, doesn’t prove testosterone is the cause. Considering the full pattern of symptoms helps prevent one lab result from overshadowing other explanations.
Assessing Symptoms and Blood Tests
Symptom assessment considers what changed, when it began, and how it affects sexual well-being and everyday function. A blood test measures testosterone, but levels can fluctuate naturally, including during the menstrual cycle. For females aged 17 to 50 years, the National Library of Medicine lists a reference range of 8.4 to 48.1 ng/dL, or 0.3 to 1.7 nmol/L. That reference range isn’t a treatment threshold, because no defined testosterone deficiency level exists for women. Testing may also assess estrogen, progesterone, and thyroid hormones, alongside total and free testosterone.
Symptoms Testosterone Therapy May Address
The strongest evidence for testosterone therapy is for postmenopausal women with low sexual desire that causes distress, after other contributing factors have been assessed. A low result alone doesn’t show that testosterone caused low libido. Evidence is insufficient to support therapy for fatigue, low energy, mood symptoms, or disease prevention. This distinction matters: a person may have several symptoms, while the evidence supports considering therapy for a narrower sexual-health concern. Treatment goals should match the evidence, rather than assume one hormone explains every change.
Causes and Alternatives to Testosterone Therapy
Testosterone levels can decline with age and may be lower after menopause or ovary removal. Premature ovarian insufficiency, adrenal insufficiency, hypopituitarism, and some medications are other possible causes. Antidepressants, pain medications, hormone medications, and chemotherapy drugs may also be associated with lower levels. Before considering treatment for low testosterone in women, evaluate other possible contributors, including medications, estrogen, thyroid function, sleep, mood, vaginal discomfort, and relationship factors. Addressing a contributing condition or considering counseling may help with libido or other symptoms without targeting testosterone. This review can clarify whether hormone therapy fits the concern.
Potential side effects of testosterone treatment
Testosterone can cause unwanted androgen-related changes, particularly when exposure exceeds the intended amount. Discuss possible effects such as a deeper voice, acne, increased hair growth, and changes in blood lipids.
Physical changes and skin effects
Possible side effects include increased hair at the cream application site, male-pattern baldness, and an enlarged clitoris. Acne may also develop or worsen. Some changes affect appearance; others, such as voice deepening, can be especially distressing. Report new symptoms promptly rather than treating them as signs that therapy is working.
Topical testosterone carries an additional exposure risk: cream can transfer from the application site to another person, particularly children or pets. Wash your hands thoroughly after applying it, let the site dry, and prevent others from touching the treated area. These steps reduce unintended contact with the medication.
Mood, irritability, and other reported effects
Mood responses can differ. Reported outcomes include less irritability, with over 90% of patients in one report describing improvement. That finding doesn’t mean testosterone reliably improves mood for every woman, or that it treats depression. Track changes in irritability, sleep, and emotional well-being alongside the original treatment goal.
Estrogen and testosterone are distinct hormones, and their related symptoms can overlap. A new mood change during testosterone use deserves attention, especially if it occurs alongside acne, unwanted hair growth, or a voice change. Recording when each effect begins can help clarify whether it followed treatment or another change.
Health conditions and precautions
Some health factors call for avoiding testosterone therapy. Listed precautions include pregnancy or breastfeeding, active liver disease, hormone-sensitive conditions, uncontrolled hyperlipidemia, and severe acne. Hormone-sensitive cancers, including breast or uterine cancer, are especially important to discuss. These conditions can change the balance of potential benefits and harms.
Before treatment, review current diagnoses and medications, including drugs that affect hormones or blood lipids. During therapy, report new acne, hair changes, or other unexpected effects rather than adjusting the dose yourself. Clinicians may monitor liver function and testosterone levels as part of follow-up.
Duration and risk discussions
Evidence on long-term safety remains limited. One cited expert advises against extending testosterone treatment beyond two years because of potential risks and limited safety research. Duration is therefore part of the decision, not an afterthought. Before therapy begins, discuss the intended symptom, signs of benefit, adverse effects, and criteria for stopping. Injections and pellets can also make hormone exposure harder to control, potentially producing very high levels and adverse effects.
Testosterone dosing and monitoring
Dosing aims to address the intended symptom while keeping testosterone levels within the premenopausal range. Regular testing and symptom reviews help guide adjustments and identify unwanted effects.
Testosterone Treatment Dosing
Dosing is individualized because products are often designed for men, and their doses need adjustment for women. Topical doses are described as about one-tenth of the dose prescribed for men. Prescription creams are available in doses considered safe for women, and clinicians may adjust the amount according to blood results and symptom response.
The goal isn’t to raise testosterone as high as possible. Treatment instead aims to keep levels within the premenopausal range while assessing the symptom being addressed, such as reduced sexual interest. Interpret lab results alongside changes in well-being, rather than using them as the sole measure of progress.
Testosterone may also affect muscle mass and strength, but those outcomes don’t establish a reason to increase the dose. If you notice new effects or no improvement, share those observations at your next clinical review. Changing the amount without that review can make symptoms and test results harder to interpret.
Monitoring Treatment and Safety
Monitoring combines blood tests with follow-up on symptoms and safety. Testosterone levels are typically checked within four to six weeks after therapy starts, then every six months. Other recommendations describe an initial check about three months after starting, followed by ongoing monitoring at least twice per year.
These checkpoints help determine whether levels remain in the intended range and whether the dose needs to change. Clinicians may monitor liver function as well as testosterone. Keeping follow-up appointments matters because a dose that seemed suitable at first may need reassessment as test results and symptoms evolve.
At each review, note whether the target symptom has changed and whether new effects have appeared. For example, record changes in sexual interest alongside acne, unwanted hair growth, or voice changes. This creates a clearer picture than relying on a general impression of feeling better or worse.
Improvements can take weeks to months to begin. If the target symptom hasn’t improved after about six months, clinicians may suggest stopping treatment. A practical monitoring plan links each blood test to a decision: continue, adjust, or reconsider therapy based on measured levels, liver function, and your response.
Testosterone therapy and breast cancer risk
Breast cancer risk is part of the decision because testosterone can interact with hormone-sensitive tissues. Short-term treatment for low libido in postmenopausal women hasn’t shown increased breast cancer risk, but long-term safety evidence remains limited.
A retrospective nine-year study followed 2,377 premenopausal and postmenopausal women using testosterone or testosterone/estradiol pellet implants. It reported 144 invasive breast cancer cases per 100,000 person-years, 35.5% below age-specific SEER rates. The study compared this finding with other population data: SEER’s age-matched incidence was 223 cases per 100,000 person-years, while the Women’s Health Initiative placebo arm reported 330, and the Million Women Study reported 312 among never-users.
Those figures describe different populations and study designs. A retrospective comparison can’t show that pellets prevented cancer or establish the risk for an individual. It also doesn’t resolve questions about long-term exposure. Consider the evidence as one part of a wider discussion, alongside personal history, current health, and the reason for therapy.
Testosterone therapy may be considered for postmenopausal women with persistent low sexual desire after other contributing factors have been evaluated. It generally isn’t recommended for women with cardiovascular disease, liver disease, or hormone-sensitive cancers, including breast or uterine cancer. Discuss a personal or family history of breast cancer before considering hormones, along with the intended treatment duration and monitoring plan.
In the United States, no specific testosterone product has FDA approval for women; use is generally off-label. Options used in practice include topical creams or gels, patches, injections, and pellets. Treatment options vary, so discuss which formulation may be appropriate with a clinician. The formulation matters: pellets release hormone over several months, making exposure less adjustable than a topical dose.
There’s no single answer about cost or insurance: expenses depend on the formulation, dispensing, and an individual plan’s coverage rules. Off-label use can affect coverage, so benefits vary by plan and prescription.
Before starting, discuss the purpose of therapy, any history of hormone-sensitive cancer, the formulation, and how follow-up will assess symptoms and safety. These details help frame the evidence honestly: a reassuring short-term finding isn’t proof of long-term safety.
Research on testosterone treatment after menopause
After menopause, testosterone research has focused most clearly on sexual desire, not fatigue or general vitality. The International Society for the Study of Women’s Sexual Health supports considering testosterone for libido in postmenopausal women. That position is specific: it doesn’t establish testosterone as a treatment for every symptom that accompanies menopause or hormonal decline.
Studies involving women already using hormone therapy have examined whether adding transdermal testosterone changes other symptoms. In one study, 510 women using hormone replacement therapy received transdermal testosterone over four months. Reported improvements included hot flushes for 55%, dizziness for 54%, musculoskeletal pain for 45%, and tension headaches for 44%. These findings are worth discussing, but they don’t demonstrate that testosterone alone caused each change.
A separate study followed 279 women already taking transdermal estradiol. After three months with added transdermal testosterone, participants reported significant improvements in 15 of 24 assessed symptoms. The study’s starting point matters: these women were already using estradiol, so the results don’t directly answer how testosterone works alone or for every woman after menopause.
Other reports describe changes in emotional symptoms. In a study of women receiving transdermal body-identical testosterone, 56% reported improvement in loss of interest in most things, while 55% reported improvement in crying spells. More than 90% of patients in another report said irritability lessened. These reported outcomes are not proof that testosterone addresses depression, fatigue, or all causes of mood changes.
Interpret the evidence by separating a measured outcome from a broad promise. A study may show that participants reported a change, but the study design, other hormones, and specific population shape what that result means. Menopause can involve overlapping symptoms, so an observed improvement doesn’t establish that a decline in testosterone caused the original complaint.
The evidence also has limits. Short-term studies haven’t shown increased cardiovascular risk, but long-term safety data remain unavailable. Hair growth and other androgen-related effects also belong in a benefit-risk discussion, particularly when research findings are used to justify treatment beyond libido. Before a clinic visit, note your main symptom, its effect on daily life, and any current hormone therapy. That helps keep the discussion tied to the outcomes studied.
The clearest takeaway is narrow: evidence and professional support are strongest for postmenopausal low libido, while findings for other symptoms remain less conclusive. Explore a broader, individualized medical perspective as you consider how hormone-related concerns fit into your overall health.
Sunridge Medical: Alternative Cancer Treatment Protocols
Sunridge Medical offers Hormone Optimization Therapy for people seeking support with hormone-related concerns. If menopause symptoms, changes in sexual interest, or questions about hormone levels are affecting your well-being, this service can be a starting point for a broader discussion of your health. Testosterone research has limits, especially for symptoms beyond low libido, so decisions benefit from careful consideration of symptoms, health history, and potential risks.
Sunridge Medical also offers Alternative Cancer Treatment Protocols, Chronic Lyme Disease Treatment, and Autoimmune Disease Management. These services address different health needs and aren’t substitutes for evaluating testosterone-related concerns. If you’re considering hormone care, contact Sunridge Medical to discuss your concerns and possible next steps.
Make Your Next Hormone-Care Decision Deliberately
A useful next step is to define what you want to change, not just which number you want to raise. Before discussing treatment for low testosterone in women, write down your most important symptoms, when they began, and how they affect daily life. Add your current medications and hormone treatments, along with questions about possible benefits, risks, and follow-up. This gives the conversation a clear purpose and connects decisions to your priorities.
Hormone concerns can intersect with broader health needs. A thoughtful discussion can clarify which concerns fit hormone-focused care and which may need a different approach. Your medical history and goals shape which options make sense, so use the conversation to understand the reasoning behind any proposed plan.
For a considered next step, contact Sunridge Medical to discuss your health concerns. Bring the questions you’ve gathered and take the time you need to make an informed decision. Clear priorities can make the path forward feel more manageable.
Frequently Asked Questions
Who should not use testosterone therapy?
Testosterone therapy should be avoided during pregnancy or breastfeeding and in some health conditions. These include active liver disease, hormone-sensitive conditions, uncontrolled hyperlipidemia, and severe acne. A history of breast or uterine cancer deserves particular attention because these cancers can be hormone-sensitive. Before considering treatment, review your diagnoses and current medications with a qualified healthcare professional, including any history that could affect hormone-related risks.
How is testosterone prescribed?
In the United States, clinicians may prescribe testosterone off-label because no specific testosterone treatment is FDA-approved for women. Options include creams, gels, patches, injections, and pellets. The selected form affects how testosterone is delivered and how readily its use can be adjusted. Since many products are designed for men, the prescribed dose must be adapted for women, with follow-up based on symptoms and blood-test results.
Should I consider testosterone replacement?
Consider discussing testosterone if low sexual desire is persistent, distressing, and especially relevant after menopause. A low laboratory result alone doesn’t establish that replacement is appropriate, and fatigue or low energy alone isn’t a well-supported reason to use testosterone. Before weighing therapy, consider whether medications, relationship concerns, sleep disruption, vaginal discomfort, or another health issue could be contributing to changes in sexual interest.
What happens if I have low testosterone?
A low result doesn’t automatically mean you’ll develop symptoms or need treatment. Some women notice changes in sexual desire or satisfaction, fatigue, or low energy; others may have no clear symptoms. Interpret the result alongside your health history and other hormone findings. Reduced energy and libido together, for example, can have several possible causes, so one testosterone measurement can’t explain the whole picture.
Why Consider Treatment?
The main reason to consider testosterone therapy is persistent low sexual desire that affects well-being, particularly after menopause. Evidence doesn’t adequately support its use for general fatigue, low mood, or disease prevention. Start the discussion by naming the symptom you want to address and how it affects you. That focus helps distinguish a targeted treatment goal from a broader hope to feel better overall.
What symptoms can low testosterone cause in women, and how is it diagnosed?
Possible symptoms include reduced sexual desire or satisfaction, fatigue, and low energy, but these can also occur with low estrogen or other health conditions. Assessment involves reviewing symptoms and measuring testosterone in a blood sample. Clinicians may also consider testing estrogen, progesterone, or thyroid function to evaluate overlapping causes. Note when symptoms began and any medication changes, as that timeline can add context to test results.
What testosterone levels are normal for women, and how reliable are blood tests?
For females aged 17 to 50 years, the National Library of Medicine lists a reference range of 8.4 to 48.1 ng/dL, or 0.3 to 1.7 nmol/L. A range doesn’t define a deficiency threshold for every woman. Blood tests measure testosterone, but levels can fluctuate naturally, including during the menstrual cycle. Clinicians interpret results alongside symptoms and may assess total and free testosterone.
When is testosterone treatment recommended for women, and for which symptoms?
Testosterone therapy is primarily considered for postmenopausal women with persistent low sexual desire after other contributing factors have been assessed. Low libido alone doesn’t prove testosterone is the cause. Evidence remains insufficient for treating other symptoms or preventing disease. If therapy is discussed, clarify the specific symptom it targets and how progress will be assessed, rather than expecting it to address several unrelated concerns at once.